What changed in IMMUCELL CORP's 2024 10-K compared to 2023?

Across the narrative sections we track, IMMUCELL CORP (ICCC) added 0 paragraphs, removed 0, and edited 0 between the 2023 and 2024 10-K filings. The biggest movers are .

Where does this ICCC 10-K diff come from?

The source filings are IMMUCELL CORP's official 2023 and 2024 Form 10-K annual reports from SEC EDGAR. 10q10k.net parses each filing, aligns paragraphs by section (Item 1, 1A, 1C, 2, 3, 7, 7A), and highlights every added, removed and edited sentence side-by-side.

IMMUCELL CORPICCC決算レポート

Nasdaq · ヘルスケア · in vitro及びin vivo診断物質

詳細分析

ImmuCell Corp is a US-based animal health biotechnology company that develops, manufactures and markets innovative products for livestock, primarily dairy cattle. Its core offerings include preventive and therapeutic solutions for common bovine health issues such as mastitis, serving agricultural producers and veterinary providers across North America.

What changed in IMMUCELL CORP's 10-K — 2023 vs 2024

No meaningful paragraph-level changes detected in the compared sections. Either the two filings are nearly identical or the sections did not parse.

Other ICCC 10-K year-over-year comparisons

ICCC 10-K 2022 vs 2023